Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

Vaccine

Volumn 16, Issue 9-10, 1998, Pages 1009-1015

  Johansson, Bert E ^a   Matthews, James T ^b   Kilbourne, Edwin D ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Div of Res/Devmt Pasteur M   (United States)

Author keywords

Influenza; Vaccine

Indexed keywords

HEMAGGLUTININ; INACTIVATED VACCINE; INFLUENZA VACCINE; MEMBRANE ANTIGEN; SIALIDASE;

ANIMAL MODEL; ANTIBODY TITER; ARTICLE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VACCINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DISEASE MODELS, ANIMAL; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; NEURAMINIDASE; PLAQUE ASSAY; SPECIES SPECIFICITY; VACCINES, INACTIVATED; VIRUS REPLICATION;

EID: 0032077894     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00279-X     Document Type: Article

References (47)

1. 1 Kida, H., Webster, R. and Yanagaw, R. Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/Seal/ Massachusetts/1/80 (H7N7) influenza virus. Arch Virology 1983, 76, 91.
2. 2 Yoden, S., Kida, H., Kawabara, M., Yanagawa, R. and Webster, R. Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody. Virus Research 1986, 4, 2510.
3. 3 Beutner, K., Chow, T., Rubi, E., Strussenberg, J., Clement, J. and Ogra, P. Evaluation of a neuraminidase-specific influenza vaccine in children: antibody responses and effects of the successive outbreak of natural infection. J. Virology 1979, 140, 8440.
4. 4 Couch, R., Kasel, J., Gerin, J., Schulman, J. and Kilbourne, E. Induction of partial immunity to influenza by a neuraminidase-specific infuenza A virus vaccine in humans. J. Infect. Dis. 1974, 129, 4110.
5. 5 Kilbourne, E., Palese, P. and Schulman, J. Inhibition of viral neuraminidase as a new approach to the prevention of influenza 1975. In: Perspectives in Virology, Vol. 9 (Ed. M. Pollard). Academic Press, New York, pp. 99-113.
6. 6 Ogra, P., Chow, T., Beutner, K., Rubi, E., Strussenberg, J., DeMello, S. and Rizzone, C. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans. J. Infect. Dis. 1977, 134, 499.
7. 7 Kilbourne, E., Laver, W., Schulamn, J. and Webster, R. Antiviral activity of antiserum specific for an influenza virus neuraminidase. I. in vitro effects. J. Virology 1968, 2, 2810.
8. 8 Johansson, B. and Kilbourne, E. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Virology 1996, 225, 1360.
9. 9 Johansson, B., Bucher, D. and Kilbourne, E. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody reponse but induce contrasting types of immunity to infection. J. Virology 1989, 63, 1239.
10. 10 Johansson, B., Moran, T., Bona, C., Popple, S. and Kilbourne, E. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience. J. Immunology 1987, 139, 2010.
11. 11 Johansson, B., Moran, T., Bona, C. and Kilbourne, E. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice. J. Immunology 1987, 139, 2015.
12. 12 Johansson, B., Moran, T. and Kilbourne, E. Antigen-presenting B cells and helper T cvells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proc. Natl Acad. Sci USA 1987, 84, 6869.
13. 13 Johansson, B. and Kilbourne, E. Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition. J. Virology 1993, 67, 5721.
14. 14 Powers, D., Kilbourne, E. and Johansson, B. Neuraminidase-specific antibody responses to inactivated influenza vaccine in young and elderly adults. Clin. Diag. Lab. Immuno. 1996, 3, 511.
15. 15 Kendal, A., Bozeman, F. and Ennis, F. Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. Infect. Immun. 1980, 29, 966.
16. 16 Kuwert, E., Hoher, P., Werner, J., Scheiermann, N., Thraenhart, O., Muller, B. and Kleber, G. Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines. In: International Symposium on Influenza Immunization (II), Vol. 39 (Ed. S. Karger, Basel). Develop. Biol. Standard., Geneva, pp. 77-83.
17. 17 Atmar, R., Keitel, W., Cate, T., Quarles, J. and Couch, R. Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults. J. Infect. Dis. 1995, 172, 2530.
18. 18 Keitel, W., Couch, R., Quarles, J., Cate, T., Baxter, B. and Maasab, H. Trivalent attenuated cold-adapted influenza virus vaccine; reduced viral shedding and serum antibody responses in susceptible adults. J. Infect. Dis. 1993, 167, 3050.
19. 19 Kilbourne, E., Grajower, B. and Johansson, B. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase. Proc. Natl Acad. Sci. USA 1990, 87, 7860.
20. 20 Johannson, B. and Kilbourne, E. Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition. Proc. Natl Acad. Sci. USA 1994, 91, 2358.
21. 21 Archetti, J. and Horsfall, F. Persistent antigenic variation of influenza A virus after incomplete neutralization in ovo with heterologous immune serum. J. Exp. Med. 1950, 92, 1521.
22. 22 Johansson, B. and Kilbourne, E. Comparative long term effects in a mouse model system of influenza whole virus vaccine and purified neuraminidase vaccine followed by sequential infections. J. Infect. Dis. 1991, 162, 800.
23. 23 Hocart, M., Grajower, B., Donabedian, A., Pokorny, B., Whitaker, C. and Kilbourne, E. Preparation and characterization of a purified influenza virus neuraminidase vaccine. Vaccine 1995, 13, 1793.
24. 24 Kilbourne, E., Couch, R., Kasel, J., Keitel, J., Cate, T., Quarles, J., Grajower, B., Pokorny, B. and Johansson, B. Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans. Vaccine 1995, 13, 1799.
25. 25 Sever, J. Application of a microtechnique to viral serological investigations. J. Immunology 1962, 88, 320.
26. 26 Jahiel, R. and Kilbourne, E. Reduction in plaque number as differing indices of influenza virus-antibody reactions. J. Bacteriology 1966, 92, 1521.
27. 27 Davenport, F. Control of influenza. Med. J. Aust. 1973, 1(suppl), 33..
28. 28 Gross, P., Quinnan, G. and Rodstein, M. et al. Association of influenza immunization with reduction in mortality in an elderly population: a prospective study. Arch. Intern. Med. 1988, 148, 5620.
29. 29 Barker, W. and Mullooly, J. Pneumonia and influenza deaths during epidemics. Implications for prevention. Arch. Intern. Med. 1982, 142, 85.
30. 30 Kilbourne, E. Influenza: viral determinants of the pathogenicity and epidemicity of an invariant disease of variable occurance. Phil. Trans. R. Soc. L. [Biol] 1980, 288, 291.
31. 31 Gross, P., Ennis, F., Gaerlan, L., Denson, L., Denning, C. and Schiffman, D. A controlled double-blind comparison of the reactogenicity, immunogenicity, and protective efficacy of whole-virus and split-product influenza vaccines in children. J. Infect. Dis. 1977, 136, 623.
32. 32 Hobson, D., Curry, A., Beare, A. and Ward-Gardner, A. Hemagglutination inhibition antibody titers as a measure of protection against influenza in man. Dev. Biol. Stand. 1973, 20, 1640.
33. 33 Kendal, A., Noble, G. and Dowdle, W. Neuraminidase content of influenza vaccines and neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations. J. Infect. Dis. 1977, 136, S145.
34. 34 Johansson, B. and Kilbourne, E. Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition. Proc. Natl Acad. Sci. USA 1994, 91, 2358.
35. 35 Kilbourne, E. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in the induction of anti-neuraminidase antibody in man. J. Infect. Dis. 1976, 134, 3840.
36. 36 Belshe, R., Swierkosz, E., Anderson, E., Newman, F., Nugent, S. and Maassab, H. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine. J. Infect. Dis. 1992, 165, 727.
37. 37 Slepushkin, A., Schild, G., Beare, A., Chinn, S. and Tyrrell, A. Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J. Hyg. 1971, 69, 571.
38. 38 Schulman, J., Khakpour, M. and Kilbourne, E. Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J. Virology 1968, 2, 778.
39. 39 Allan, W., Madeley, C. and Kendal, A. Studies with avian influenza A viruses: cross protection experiments in chickens, J. Gen. Virology 1971, 12, 79.
40. 40 Rott, R., Becht, H. and Orlich, M. The significance of influenza virus neuraminidase in immunity. J. Gen. Virology 1974, 22, 35.
41. 41 Webster, R., Reay, P. and Laver, W. Protection against lethal influenza with neuraminidase. Virology 1988, 164, 230.
42. 42 Price, P., Reichelderfer, C., Johansson, B., Kilbourne, E. and Acs, G. Complementation of recombinant baculovirus by coinfection with wild-type virus facilitates production in insect larvae of antigenic proteins of hepatitis B virus and influenza virus. Proc. Natl Acad. Sci. USA 1989, 86, 1453.
43. 43 Johansson, B., Price, P. and Kilbourne, E. Immunogenicity of influenza A virus N2 neuraminidase produced in insect larvae by baculovirus recombinants. Vaccine 1995, 9, 841.
44. 44 Erickson, A. and Kilbourne, E. Comparative amino acid analysis of influenza A viral proteins. Virology 1980, 100, 34.
45. 45 Wiley, D., Wilson, I. and Skehel, J. Structural identification of the antibody-binding sites of Hong Kong influenza hemagglutinin and their involvement in antigenic variaion. Nature 1981, 289, 373.
46. 46 Varghese, J., Laver, W. and Coleman, P. Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 1983, 303, 35.
47. 47 Coleman, P., Varghese, J. and Laver, W. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 1983, 303, 41.